BEHAVIORAL HEALTH
Research-Grade
Real-world data
NeuroBlu Data is the largest source of longitudinal, NLP-enriched real-world neuropsychiatry data for clinical insights.
Patients
Geographically-diverse health systems
Years of longitudinal data
Connects patient data across time and care settings to enable longitudinal analysis and richer clinical insights.
Over 20 years of neurology, behavioral health, mental health, and neuropsychiatry data from diverse care environments including inpatient, outpatient, emergency, crisis, and community settings.
Combines structured data with NLP-enriched clinical notes to support multidimensional cohort development and outcomes research.
Offers validated neuropsychiatry variables—assessments, symptoms, testing, and interventions—for advanced analytics and decision-making.
NeuroBlu platform seamlessly connects our behavioral health data and analytics capabilities with our behavioral health expertise to bring specialized solutions to customers across the healthcare ecosystem.
We recognize that diverse neuropsychiatry challenges require tailored solutions.
Behavioral health is a fundamental and persistently overlooked aspect of overall health. Mental and substance use disorders impact a staggering 970 million people worldwide, with over US $1 trillion in global economic burden each year. Despite the skyrocketing crisis, progress has lagged behind other disease areas. Less than half of those living with major depression, the most widespread mental illness, reach remission on currently available treatments. Recent rising awareness has driven demand in a system unequipped to support the depth and breadth of need.
There is a debilitating evidence gap that inhibits research and innovation, stemming from inherent limitations in behavioral health: complex disease etiologies, lack of quantifiable biomarkers, and institutional silos. Despite decades of research, we still do not know how to alleviate most behavioral health disorders.
We need new solutions, and we need them now.
Trusted by stakeholders committed to improving neuropsychiatry through better evidence.
NeuroBlu has supported diverse stakeholders produce publication-ready neuropsychiatry research, including collaborative projects with:
Analyzed healthcare resource utilization rates for patients with schizophrenia and bipolar disorder; work was published in Current Medical Research and Opinion
Read MoreCreated, trained, and tested a predictive model to better understand indicators of increased hospitalization risk for patients with major depressive disorder; work was presented at ISPOR Europe
Read MoreExplored factors that impact attrition from treatment in patients with opioid use disorder; work was published inNeuropsychiatric Disease and Treatment
Read More
